Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients

Figure 1 Histogram of clinical efficiency and incidence of adverse reaction between the two groups. A: Histogram of clinical efficiency; B: Incidence of adverse reaction.

Figure 2 The optical coherence tomography test results of before and after patient treatment. A: The test result of optical coherence tomography before the treatment, where macular edema was obvious; B: Re-examination after 1 wk of treatment, where the macular edema is slightly relieved; C: Re-examination after 1 month of treatment, where the macular edema was significantly reduced; D: The condition of the patient 3 mo post-treatment, where the macular edema has nearly disappeared, and the choroid thickness has become significantly thinner.